Table 1

Labelling and tracking stem cells in neurological diseases

DiseaseCell typeTracking technologyTracerSpeciesReferences
StrokeMSCMRIMolday ION-Rhodamine BPigs/dogs/ RatsWalczak et al, 201751
StrokeMSCMRI/NIRFBCN-dual-NPsMiceLim et al, 201952
StrokeMSCMRI/PAIGRMNBsMiceChen et al, 201553
StrokeNSCMRI/FLILV-FTH-EGFPMiceZhang et al, 201754
StrokeMSCMRI/SPECT/CT 125I-fSiO4@SPIOsRatsTang et al, 201555
PDNSCMRIMNPRatsGomez et al, 201510
ADMSCMRIFerumoxytolMiceLee et al, 201767
ALShGRPMRIPFCMiceRichard et al, 201972
TBIiPS cellMRISPIORatsJiang et al, 201978
SCIBM-MSCMRIGd-DTPA-FARatsZhang et al, 201786
  • AD, Alzheimer’s disease; ALS, amyotrophic lateral sclerosis; BCN-dual-NPs, bicyclic nonyne conjugated ethylene glycol chitosan nanoparticles; BM-MSC, bone marrow mesenchymal stem cell; iPS cell, induced pluripotent stem cell; FLI, fluorescence imaging; Gd-DTPA-FA, gadolinium-dimethylene penta-acetic acid-containing nanoparticles; GRMNBs, multi-gold nanorods crystal-seeded magnetic mesoporous silica nanobeads; hGRP, human glial-restricted progenitor; 125I-fSiO4@SPIOs, fluorescent silica-coated SPIOs with 125iodine; LV-FTH-EGFP, a lentiviral vector encoding ferritin heavy chain (FTH) and enhanced green fluorescent protein (EGFP); MNP, magnetic nanoparticle; MSC, mesenchymal stem cells; NIRF, near-infrared fluorescent; NSC, neural stem cell; PAI, photoacoustic imaging; PD, Parkinson’s disease; PET, positron emission tomography; PFC, perfluorocarbon; SCI, spinal cord injury; SPECT, single-photon emission CT; SPIO, superparamagnetic iron oxide; TBI, traumatic brain injury.